Question? Reach Us: (949) 990-4490
Tirzepatide

Ideal for

  • Individuals seeking medical weight management
  • Those experiencing appetite control challenges
  • Individuals seeking long-term weight management support

GIPGLP-1

Tirzepatide

Tirzepatide (GIP/GLP-1 Receptor Agonist) / Methylcobalamin

Tirzepatide is a dual GIP and GLP-1 receptor agonist that may be prescribed as part of a medically supervised weight management program. It works by affecting pathways involved in appetite and satiety. Treatment is available only when determined appropriate by a licensed healthcare provider.

  • Supports Weight Management — May support weight management as part of a medically supervised treatment plan.
  • Supports Appetite Control — Acts on GIP and GLP-1 pathways involved in appetite and feelings of fullness.
  • Supports Healthy Lifestyle Changes — May complement nutrition, physical activity, and other lifestyle changes recommended by our healthcare provider
  • Tirzepatide (GLP‑1 & GIP receptor agonist): Harnesses dual incretin hormone pathways to enhance insulin release, suppress glucagon, slow gastric emptying, reduce appetite, and improve glycemic control—effective for both type 2 diabetes and weight management.
  • Glycine: A non-essential amino acid that supports muscle preservation, exerts anti-inflammatory effects (reducing cytokines like TNF‑α, IL‑6, and IL‑1β), and aids physical performance—helpful during weight loss.
  • Cyanocobalamin (Vitamin B₁₂): A water‑soluble B‑vitamin that supports energy production, red blood cell synthesis, and may help reduce nausea associated with GLP‑1-based therapies.

Tirzepatide is available as a subcutaneous injection. It is typically used once a week and can be administered in different areas of the body. For personalized instructions and support, please reach us out.

Q: What is Tirzepatide used for?
A: Tirzepatide may be prescribed for weight management when determined medically appropriate by our licensed healthcare provider.

Q: How is Tirzepatide taken?
A: Tirzepatide is administered by subcutaneous injection according to your prescribed dosing instructions.

Q: What results can I expect?
A: Results vary by individual. Our healthcare provider will determine whether treatment is appropriate and monitor your progress.

Q: Is Tirzepatide safe?
A: Tirzepatide may cause side effects and is not appropriate for everyone. Our healthcare provider will review your health history, potential risks, and treatment options before prescribing.

Q: Why is a medical evaluation required?
A: Our licensed healthcare provider must evaluate your health information to determine whether Tirzepatide is medically appropriate for you.

  1. Drugs.com. (2025). Tirzepatide: Uses, Side Effects & Information. Retrieved from Drugs.com.
  2. Mayo Clinic. (2025). Tirzepatide (subcutaneous route) – Overview. Retrieved from Mayo Clinic.
  3. Strive Pharmacy. (2024). Tirzepatide / Glycine / B12. Retrieved from Strive Pharmacy.
  4. WellsRx. (2025). Tirzepatide with Glycine. Retrieved from WellsRx.
  5. DrWell. (2025). Tirzepatide + Glycine + B12 for Weight Loss. Retrieved from DrWell
  6. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., & Frias, J. P. (2022). Tirzepatide once weekly for the treatment of obesity. The New England Journal of Medicine, 387(3), 205-216.
  7. Frias, J. P., Nauck, M. A., Van, J., Kutner, M. E., Cui, X., Benson, C., & Urva, S. (2021). Efficacy and safety of Tirzepatide, a dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes (SURPASS-2). The New England Journal of Medicine, 385(6), 503-515.
  8. Office of Dietary Supplements – Vitamin B12. (n.d.). National Institutes of Health

Related Products

Want to Know More About Our Products?